Human Immunodeficiency Virus (HIV) Type-1 GP120-Specific Cell-Mediated Cytotoxicity (CMC) and Natural Killer (NK) Activity in HIV-Infected (HIV+) Subjects: Enhancement with Interleukin-2(IL-2), IL-12, and IL-15
- 28 February 1997
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 82 (2), 163-173
- https://doi.org/10.1006/clin.1996.4298